---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-020489"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:02:21.214171+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q1 revenue $2.2M, net loss narrows to $0.5M; generates positive operating cash flow

## Summary
- Revenue $2.2M flat YoY, up 19.5% QoQ; gross margin improved to 86.3% from 40% on higher license mix and prior hardware reserve.
- Net loss $0.5M ($0.32/sh) vs $1.7M ($3.51/sh) in Q1'23; operating cash flow positive $0.3M vs $1.9M used.
- Operating expenses cut 9% to $2.4M; cash and equivalents $690K; accounts receivable $710K.
- Expanded biometric deployment with long-term financial client drove license fee revenue up 23.6% YoY.

## SEC filing metadata
- accession: 0001437749-24-020489
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774924020489/0001437749-24-020489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774924020489/bkyi20240617_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-020489
- JSON: https://secwatch.observer/filing/0001437749-24-020489.json
- Plain text: https://secwatch.observer/filing/0001437749-24-020489.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.